Comparing conversational software and standard digital questionnaires for people with chronic pain
Official title: Evaluating the Acceptability, Feasibility and Usability of Various Digital Biopsychosocial Conversational Data Collection Software in a Patient Population With Chronic Pain
Run by AugMend Health Inc. · NCT07336537 · Data updated 2026-11-12
This project will try conversational software and standard digital questionnaires to see which is easier and more useful for adults living with chronic pain.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | AugMend Health Inc. Industry-sponsored |
| Locations | 1 site (Cambridge, Massachusetts) |
| Status | Recruiting |
| Started | October 3, 2025 |
| Main results expected | February 11, 2026 |
| Study ends | July 31, 2026 |
| Registry record updated | January 13, 2026 |
| Trial ID | NCT07336537 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with chronic pain lasting at least three months who can read English, provide informed consent, and use digital devices are appropriate candidates.
✕Probably not a fit
People with only acute pain, significant cognitive impairment preventing meaningful interaction, non-English speakers, or those without access to required technology are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This comparative study assigns adults with chronic pain to use different digital tools—conversational software or standard questionnaires—either at home or in the MIT.nano Immersion Lab. Researchers will measure acceptability, feasibility, and usability, and compare user experience, data completeness, and practical implementation considerations across platforms. Participants will interact with the tools, answer biopsychosocial questions about symptoms and daily life, and provide feedback on clarity, convenience, and any technical issues. The goal is to identify which digital approaches best capture comprehensive patient-reported information to inform clinical workflows.
Why it matters
Potential benefit: If successful, these tools could make it easier for patients to report physical, emotional, and social symptoms and help clinicians get more complete biopsychosocial information.
How similar studies have gone: Digital questionnaires and ecological momentary assessment have been used successfully to capture patient-reported outcomes, but conversational data-collection platforms are relatively new and less extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years or older * Diagnosis of chronic pain (pain lasting 3 months or longer) * Able to read and understand English * Able to provide informed consent * Willing and able to complete study procedures either at home or at the MIT.nano Immersion Lab * Access to necessary technology for home-based participation (if assigned to home-based group), or ability to travel to the MIT.nano Immersion Lab (if assigned to laboratory-based group) * Cognitively able to interact with digital data collection software and provide feedback Exclusion Criteria: * Under 18 years of age * Unable to provide informed consent * Non-English speaking * Acute pain only (pain lasting less than 3 months) * Cognitive impairment that would prevent meaningful interaction with data collection software or ability to provide valid feedback * Unable or unwilling to complete study procedures in assigned setting (home or laboratory) * Any condition that, in the opinion of the investigator, would make participation unsafe or interfere with the participant's ability to complete study procedures
Where it's running
-
AugMend Health at MIT.nano Immersion Lab
Cambridge, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Mark Ruchman, MD — AugMend Health
- Study coordinator: Mark Ruchman, MD
- Email: mruchman@augmend.health
- Phone: +1 (203) 598-9557
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
Cebranopadol for opioid withdrawal in adults with chronic pain
This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.